CRE Investment Guide: Boston Market Overview
Boston's still the East Coast's most consistent play outside Manhattan. The life sciences boom isn't going anywhere, higher ed anchors the economy, and institutional money keeps flowing in. Yeah, permitting's a nightmare and linkage fees hurt, but cap rates reflect the stability. If you can stomach the entry costs and regulatory maze, fundamentals remain strong.
Market Snapshot
population
Metro area sits at 4.9 million, city proper around 695K. Population growth modest at 0.8% annually but household formation strong among 25-40 demographic.
gdp growth
Regional GDP up 2.1% year-over-year, outpacing national average. Knowledge economy jobs driving growth with average wages 18% above national median.
major employers
Mass General Brigham, Harvard, MIT, Moderna, Biogen, State Street, Fidelity, Amazon, Google. Life sciences cluster employs 85K+ people directly.
employment trends
Unemployment at 3.2%, tech hiring rebounded after 2024 slowdown. Lab technician and biotech engineering roles seeing 12-15% wage growth. Office jobs still hybrid but return-to-office mandates increasing.
infrastructure
MBTA's reliability improved but still inconsistent. Logan Airport capacity constraints ongoing. Seaport infrastructure upgrades nearly complete. I-95/Route 128 congestion remains major issue.
demographic profile
Highly educated population - 47% hold bachelor's degree or higher. Median household income $89K citywide, $125K+ in Cambridge/Newton. Young professional population churns but consistently replaced.
Property Type Performance
Lab/Life Sciences
3.8%-4.5% capVacancy
2.1%
Rent Trend
Up 8-12% annually, $85-120/SF in Cambridge/Kendall
Supply Pipeline
3.2M SF under construction, mostly pre-leased. Demand still outpaces supply.
Investment Thesis
Premium asset class with long-term leases and credit tenants. Kendall Square trades like Manhattan now but fundamentals justify pricing.
Risks
Specialized asset, limited tenant pool, high conversion costs if biotech demand softens.
Multifamily
4.2%-5.8% capVacancy
4.8%
Rent Trend
Up 6-9% annually, $2,800-4,200 average rent
Supply Pipeline
8,500 units under construction citywide, concentrated in Seaport and Assembly Row
Investment Thesis
Strong job growth and limited land supply support rents. Luxury segment performing best, affordable housing mandates create complications.
Risks
Rent control expansion risk, BPDA affordable housing requirements, interest rate sensitivity.
Office
5.5%-8.5% capVacancy
18.2% CBD, 22.1% suburban
Rent Trend
CBD flat to down 2%, suburban down 8-15%
Supply Pipeline
Limited new construction, several conversions to residential planned
Investment Thesis
Flight to quality ongoing. Class A buildings in Financial District and Back Bay holding value, everything else struggling.
Risks
Permanent WFH adoption, obsolete building stock, high conversion costs for older properties.
Retail
5.2%-7.8% capVacancy
11.5%
Rent Trend
Mixed - street retail up 3-5%, strip centers flat
Supply Pipeline
Minimal new construction, focus on repositioning existing assets
Investment Thesis
Newbury Street and North End performing well. Neighborhood retail benefits from walkable density.
Risks
E-commerce pressure continues, foot traffic still below pre-2020 levels in some areas.
Industrial
6.2%-7.5% capVacancy
5.9%
Rent Trend
Up 4-7% annually, supply constraints driving increases
Supply Pipeline
Limited developable land, mostly infill and redevelopment projects
Investment Thesis
Last-mile delivery demand strong, constrained supply in metro area. Cold storage particularly tight.
Risks
Land costs make new development challenging, truck traffic restrictions in some municipalities.
Hotel
7.2%-9.8% capVacancy
N/A - occupancy at 72%
Rent Trend
ADR recovering, up 11% year-over-year to $245
Supply Pipeline
Three new hotels opening in 2026, mostly select-service
Investment Thesis
Business travel recovery ongoing, leisure demand strong. Convention business improving.
Risks
Interest rate sensitivity, labor cost inflation, potential recession impact on travel.
Investment Thesis
Boston rewards patient capital and local expertise. The regulatory environment favors established players who know how to work the system. Life sciences will drive returns for the next decade, but don't ignore strong multifamily fundamentals.
Risk Factors
BPDA permitting delays and affordable housing mandates
HighBuild relationships early, hire experienced local counsel, factor delays into proformas
Interest rate sensitivity on leveraged deals
MediumConservative leverage, rate caps, focus on cash-flowing assets
Biotech cycle downturn affecting lab demand
MediumDiversify tenant base, avoid single-tenant lab deals, consider conversion flexibility
Rent control expansion beyond current scope
MediumMonitor political developments, focus on owner-occupied and commercial assets
Climate change regulations increasing operating costs
LowEnergy efficiency upgrades, factor carbon costs into underwriting
Recent Transactions
| Property | Type | Price | Cap Rate | Date |
|---|---|---|---|---|
One Kendall Square Lab Complex 341K SF fully leased to Moderna and Vertex, 12-year WALT | Lab/Life Sciences | $485 million | 4.1% | February 2026 |
Seaport Luxury Apartments 262 units, delivered 2023, 96% occupied, $3,200 average rent | Multifamily | $127 million | 4.6% | January 2026 |
100 Federal Street Office Tower 800K SF Financial District tower, 78% leased, recent capital improvements | Office | $340 million | 6.8% | December 2025 |
Assembly Row Mixed-Use 301K SF retail and restaurant space, 89% occupied, strong foot traffic | Retail | $95 million | 6.2% | November 2025 |
Logan Airport Area Industrial 255K SF warehouse, 24-foot clear height, fully leased to logistics tenants | Industrial | $42 million | 6.9% | January 2026 |
Marketing a property in Boston?
DealDraft generates professional offering memorandums with market-specific analysis built in.
Create Your OM